Otros idiomas Chengdu Olymvax Biopharmaceuticals Inc.

Acciones

688319

CNE1000051H8

Precio de cierre Shanghai S.E. Otros sitios de cotización 00:00:00 26/06/2024			Varia. Cinco días.	Varia. 1 de enero.
9,64 ^CNY	+2,01 %		-0,21 %	-38,99 %

25/04	Chengdu Olymvax Biopharmaceuticals Inc. presenta los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI
27/02	Chengdu Olymvax Biopharmaceuticals Inc. presenta los resultados del ejercicio cerrado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Olymvax Biopharma's Flu Vaccine Gets China Nod for Clinical Trials	16/05
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/02
Olymvax Biopharmaceuticals Withdraws Application for Combined Influenza Vaccine	02/02
Olymvax Biopharmaceuticals Grants Keyuan Xinhai Marketing Rights for Meningococcal Vaccines	12/12
Olymvax Biopharmaceuticals to Push Through Phase III Trial Into Recombinant Staphylococcus Aureus Vaccine	21/11
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23
Chengdu Olymvax Biopharmaceuticals Inc.(XSSC:688319) added to S&P Global BMI Index	18/09/23
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	17/08/23
Chinese healthcare stocks hit by stepped up anti-graft crackdown	09/08/23
Olymvax Biopharma Gets Nod to Amend Packaging of Adsorbed Tetanus Vaccine	12/07/23
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	28/10/22
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	17/08/22
Chengdu Olymvax Biopharmaceuticals Inc.(SHSE:688319) added to Shanghai Stock Exchange A Share Index	08/06/22
Chengdu Olymvax Biopharmaceuticals Inc.(SHSE:688319) added to Shanghai Stock Exchange Composite Index	08/06/22
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	28/04/22
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22/02/22
Chengdu Olymvax Biopharmaceuticals Inc. Reports Earnings Results for the Nine Months Ended September 30, 2021	29/10/21

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Chengdu Olymvax Biopharmaceuticals Inc.

Acciones

688319

CNE1000051H8

Otros idiomas

Filtros